Journal of Clinical Endocrinology & Metabolism, Vol 57, 1221-1225, Copyright © 1983 by Endocrine Society

ARTICLES

Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease

CM Gundberg, JB Lian, PM Gallop and JJ Steinberg

Osteocalcin is a major bone matrix protein with high affinity for hydroxyapatite. This property is conferred by several residues of the calcium-binding amino acid gamma-carboxyglutamate (Gla), which requires vitamin K for its biosynthesis. Because this protein may play a role in the local control of calcium deposition or removal in mineralized tissue, we measured circulating osteocalcin levels and urinary excretion of its breakdown product, Gla, in patients with osteoporosis and Paget's disease. Studies were conducted either on a metabolic ward or in ambulatory patients. Diagnoses were established by clinical and laboratory findings, and were confirmed by histological examination in 19 of 26 patients with osteoporosis. Mean urinary Gla excretion was increased (P less than 0.001) in patients with osteoporosis by 50% above the normal mean; serum osteocalcin, however, was not significantly different from normal. In Paget's disease patients, this pattern was reversed; serum osteocalcin levels were increased 3-fold (P less than 0.001), while urinary Gla excretion was consistently normal, regardless of the extent or activity of the disease. These data demonstrate that measurements of urinary Gla and serum osteocalcin may provide important insights into the metabolic derangements in these and other bone disorders.

This article has been cited by other articles:

				K. K. Ivaska, S.-M. Kakonen, P. Gerdhem, K. J. Obrant, K. Pettersson, and H. K. Vaananen Urinary Osteocalcin as a Marker of Bone Metabolism Clin. Chem., March 1, 2005; 51(3): 618 - 628. [Abstract] [Full Text] [PDF]

				P. B Rapuri, J C. Gallagher, K. E Balhorn, and K. L Ryschon Alcohol intake and bone metabolism in elderly women Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1206 - 1213. [Abstract] [Full Text] [PDF]

				B. L Salle, E. E Delvin, A. Lapillonne, N. J Bishop, and F. H Glorieux Perinatal metabolism of vitamin D Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1317S - 1324. [Abstract] [Full Text] [PDF]

				A. M. Craciun, C. Vermeer, H.-G. Eisenwiener, N. Drees, and M. H.J. Knapen Evaluation of a Bead-based Enzyme Immunoassay for the Rapid Detection of Osteocalcin in Human Serum Clin. Chem., February 1, 2000; 46(2): 252 - 257. [Abstract] [Full Text] [PDF]

				J. W. Colford, B. A. Lueddecke, M. Salvati, D. Hanna, D. Sailer, S. Khosla, B. L. Riggs, and C. B. Langman Immunoradiometric Assay for Intact Human Osteocalcin(1–49) without Cross-Reactivity to Breakdown Products Clin. Chem., April 1, 1999; 45(4): 526 - 531. [Abstract] [Full Text] [PDF]

				M. Cioffi, A. M. Molinari, P. Gazzerro, B. Di Finizio, M. Fratta, A. Deufemia, and G. A. Puca Serum Osteocalcin in 1634 Healthy Children Clin. Chem., March 1, 1997; 43(3): 543 - 545. [Full Text]

				F. Yeung, W. K. Law, C.-H. Yeh, J. J. Westendorf, Y. Zhang, R. Wang, C. Kao, and L. W. K. Chung Regulation of Human Osteocalcin Promoter in Hormone-independent Human Prostate Cancer Cells J. Biol. Chem., January 18, 2002; 277(4): 2468 - 2476. [Abstract] [Full Text] [PDF]